The results of this study showed good agreement with previously reported analysis of COVID-19 plasma regarding common acute phase markers such as AZGP1 ORM, CRP, SAA1, HP, ORM, HPR and B2M that were increased in COVID-19 patients [1–11], that confirmed the sampling scheme, instrumental analysis and computations were successful. This evidence concerns the gene B2M and COVID-19.